| Results 351 - 400 of 1412 | ||
| < 3 4 5 6 7 8 9 10 11 12 13 > | ||
|
Shrubsole-Cockwill, A. - - 2009
|
||
|
Beltran-Alcrudo, D. - - 2009
|
||
|
Davis, M.R. - - 2009
|
||
|
Atkinson, Carter - - 2009
|
||
|
Smith, Stephen - - 2009
|
||
|
Mickley, Kimberly - - 2009
|
||
|
Simova-Curd, Stefka - - 2009
|
||
|
Evans, Erika - - 2009
|
||
|
Barron, Heather - - 2009
|
||
|
Krautwald-Junghanns, Maria-Elisabeth - - 2009
|
||
|
Briggs, Brandon - - 2009
|
||
|
Styer, Susan - - 2009
|
||
|
Zakowski, Maureen - - 2009
* Context.--A subset of lung adenocarcinomas appears preferentially
sensitive to epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors (TKIs). EGFR-activating mutations and never smoking are
associated with response to TKIs.
|
||
|
Ramsey, Glenn - - 2009
* Context.--Rh(D)-negative women with a large fetomaternal
hemmorrahage (FMH) from an Rh(D)-positive fetus are at risk for anti-D
alloimmunization if they do not receive adequate Rh immune glbulin
(RhIG). Determination of the adequate RhIG dose for these women is a
critical laboratory procedure for protecting their future Rh(D)-positive
children.
|
||
|
Klimstra, David - - 2009
* Context.--The pancreas gives rise to an array of distinct
neoplasms that can be solid, cystic, or intraductal and can recapitulate
the various lines of differentiation present in the normal gland.
|
||
|
Zamboni, Giuseppe - - 2009
* Context.--A variety of nonneoplastic conditions may form
pancreatic masses that mimic carcinoma. Approximately 5% to 10% of
pancreatectomies performed with the clinical diagnosis of pancreatic
cancer prove on microscopic evaluation to be pseudotumors.
|
||
|
Basturk, Olca - - 2009
* Context.--Cystic lesions of the pancreas are being recognized with increasing frequency and have become a more common finding in clinical practice because of the widespread use of advanced imaging modalities and the sharp drop in the mortality rate of pancreatic surgery. Consequently, in the past 2 decades, the nature ...
|
||
|
Yachida, Shinichi - - 2009
* Context.--Metastatic disease is the most critical determinant of
resectability of pancreatic cancer and accounts for the poor outcome of
patients with this disease. Thus, a better understanding of metastatic
pancreatic cancer will afford new opportunities for therapeutic
intervention.
|
||
|
Ranganathan, Prathibha - - 2009
* Context.--Pancreatic cancer is one of the leading causes of cancer-related deaths. Most cases are diagnosed at an advanced stage when the disease is beyond surgical intervention. Molecular studies during the past decade have contributed greatly to our understanding of this disease. Various germ-line and somatic mutations associated with pancreatic ...
|
||
|
Bellizzi, Andrew - - 2009
* Context.--Pancreatic cytopathology plays an important role in the
diagnosis and management of patients with solid and cystic lesions of
the pancreas.
|
||
| < 3 4 5 6 7 8 9 10 11 12 13 > | ||